Sitemap
January 11, 2014 Articles
Filter by Available Specialty
- Cancer institute leader elected to ASCO board of directors
- FDA approves Farxiga to treat type 2 diabetes
- ISTO Technologies appoints new CEO, board of director member
- JDRF, University of Michigan partner on type 1 diabetes beta-cell project
- Nanosphere receives FDA clearance for gram-negative bacteria test
- Risk for CV events lower with oral estradiol vs. equine estrogen